Guggenheim Capital LLC Meridian Bioscience Inc Transaction History

Guggenheim Capital LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $542,477 - $581,486	17,415 Added 250.04%	24,380 $809,000
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $215,218 - $233,675	6,965 New	6,965 $220,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $216,067 - $267,423	-12,375 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $174,992 - $226,935	-10,086 Reduced 44.9%	12,375 $238,000
Q2 2021 Aug 13, 2021	SELL	$18.01 - $28.32 $29,140 - $45,821	-1,618 Reduced 6.72%	22,461 $498,000
Q1 2021 May 13, 2021	SELL	$19.76 - $29.89 $412,213 - $623,535	-20,861 Reduced 46.42%	24,079 $632,000
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $706,906 - $973,400	44,940 New	44,940 $840,000
Q3 2019 Nov 14, 2019	SELL	$9.17 - $12.01 $235,934 - $309,005	-25,729 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$10.88 - $17.6 $177,713 - $287,478	-16,334 Reduced 38.83%	25,729 $305,000
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $16,207 - $18,402	-1,045 Reduced 2.42%	42,063 $741,000
Q4 2018 Feb 14, 2019	SELL	$14.52 - $19.72 $212,674 - $288,838	-14,647 Reduced 25.36%	43,108 $749,000
Q3 2018 Nov 14, 2018	BUY	$14.85 - $16.35 $12,889 - $14,191	868 Added 1.53%	57,755 $860,000
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $224,098 - $272,815	16,239 Added 39.95%	56,887 $904,000
Q1 2018 May 15, 2018	BUY	$13.8 - $16.2 $203,646 - $239,063	14,757 Added 57.0%	40,648 $578,000
Q4 2017 Feb 14, 2018	SELL	$13.55 - $15.8 $153,900 - $179,456	-11,358 Reduced 30.49%	25,891 $364,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $500,999 - $534,523	37,249	37,249 $533,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.